1 YEAR Institute for Interventional Pain Medicine SZ AG – A milestone under the banner ‘Less pain for more quality of life.’
What began a year ago with a clear vision – modern, targeted, and patient-centered pain medicine in the heart of Central Switzerland – has, after just one year, become an established point of contact for people living with chronic pain. In this first year, we had the privilege of supporting numerous patients on their journey to a better quality of life, offering hope and relief through modern interventional methods.
Building a specialized pain medicine institute requires dedication, expertise, and interdisciplinary collaboration. We are proud of our committed team, who work every day with empathy and skill to find and implement individual solutions for complex pain conditions.
Our special thanks go to all patients, referring physicians, and healthcare partners who have placed their trust in us. Your positive feedback and the visible progress inspire us to continue on our path with determination and to constantly improve and expand our services.
This anniversary is not an endpoint for us, but rather a first step. In the coming year, we are fully committed to further strengthening and expanding the high standard of care we provide – for a better, pain-free future.
We are also pleased to announce that our team will be growing in the coming months. Dr. Tobias Tessmann, with whom we already had the pleasure of working at Spital Lachen AG, will begin supporting us in pain medicine – part-time from June, and with a regular presence and his own consultation hours starting in July.
THANK YOU FOR A MOVING FIRST YEAR!
Your team at the Institute for Interventional Pain Medicine SZ AG
Subscribe to Newsletter
We’d be happy to share more about us and our services in the next newsletter and on www.issz.ch.
Current Affairs
Further News & Publications
Team – Dr. med. T. Tessmann #NewDoctor #NewPainSpecialist
From June, Dr. Tobias Tessmann will join ISSZ. He already worked as a resident in anesthesiology at Spital Lachen from 2019-2021 together with Dr. J.
Certification as an SSIPM Training Centre Pain Clinic B
We recently announced that we would apply for certification as an SSIPM training centre “Pain Clinic B”. We are now very pleased to have received
Cooperation with the Institute for Interventional Pain Medicine Zurich AG (IISZ)
Similar to the long-standing, close friendship and professional relationship between Jan Ludwigs and Daniel Friis, the connection between the ISSZ and the Institute for Interventional
Suzetrigin: A Novel Pain Medication in Switzerland
Suzetrigin (brand name: Journavx™) is an innovative, non-opioid analgesic that was approved in January 2025 by the U.S. FDA for the treatment of moderate to
Pulsed Radiofrequency Treatment (pRF)
Die gepulste Radiofrequenz-Behandlung (pRF) stellt eine minimalinvasive, nicht-destruktive Methode zur Behandlung
chronischer Schmerzen dar. Im Gegensatz zur thermischen Radiofrequenzablation, die durch Hitzeeinwirkung Nerven
Neuromodulation: Innovative Approaches to Chronic Pain
The term neuromodulation encompasses a variety of established therapeutic methods, including not only spinal epidural neurostimulation (Spinal Cord Stimulation – SCS), which is often used
Team – Dr. med. T. Tessmann #NewDoctor #NewPainSpecialist
From June, Dr. Tobias Tessmann will join ISSZ. He already worked as a resident in anesthesiology at Spital Lachen from 2019-2021 together with Dr. J.
Certification as an SSIPM Training Centre Pain Clinic B
We recently announced that we would apply for certification as an SSIPM training centre “Pain Clinic B”. We are now very pleased to have received
Cooperation with the Institute for Interventional Pain Medicine Zurich AG (IISZ)
Similar to the long-standing, close friendship and professional relationship between Jan Ludwigs and Daniel Friis, the connection between the ISSZ and the Institute for Interventional
Suzetrigin: A Novel Pain Medication in Switzerland
Suzetrigin (brand name: Journavx™) is an innovative, non-opioid analgesic that was approved in January 2025 by the U.S. FDA for the treatment of moderate to
Pulsed Radiofrequency Treatment (pRF)
Die gepulste Radiofrequenz-Behandlung (pRF) stellt eine minimalinvasive, nicht-destruktive Methode zur Behandlung
chronischer Schmerzen dar. Im Gegensatz zur thermischen Radiofrequenzablation, die durch Hitzeeinwirkung Nerven
1 year of Interventional Pain Medicine SZ AG – Less pain, more quality of life
On 3 May 2025, we celebrated the one-year anniversary of the Institute for Interventional Pain Medicine SZ AG – a significant milestone on our journey